Paclitaxel 175 or 225 mg per Meters Squared With Carboplatin in Advanced Ovarian Cancer: A Randomized Trial
Author(s) -
Giorgio Bolis,
Giovanna Scarfone,
Gianpiero Polverino,
Francesco Raspagliesi,
Saverio Tateo,
G Richiardi,
Mauro Melpignano,
Massimo Piergiuseppe Franchi,
Giorgia Mangili,
M. Presti,
Antonella Villa,
Enrico Conta,
Paolo Guarnerio,
Sonia Cipriani,
Fabio Parazzini
Publication year - 2004
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2004.03.017
Subject(s) - carboplatin , medicine , paclitaxel , ovarian cancer , urology , randomized controlled trial , chemotherapy , gastroenterology , cancer , cisplatin
To analyze the effect of different doses of paclitaxel with fixed doses of carboplatin in the treatment of ovarian cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom